|
PIGG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.047700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.305000E-01 |
| Normal-vs-Stage2 |
3.220600E-01 |
| Normal-vs-Stage3 |
9.376500E-04 |
| Normal-vs-Stage4 |
6.504400E-02 |
| Stage1-vs-Stage2 |
8.799200E-01 |
| Stage1-vs-Stage3 |
1.818400E-03 |
| Stage1-vs-Stage4 |
2.014800E-01 |
| Stage2-vs-Stage3 |
5.582400E-02 |
| Stage2-vs-Stage4 |
4.617800E-01 |
| Stage3-vs-Stage4 |
2.512000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.313600E-02 |
| Normal-vs-AfricanAmerican |
6.659200E-01 |
| Normal-vs-Asian |
8.335800E-01 |
| Caucasian-vs-AfricanAmerican |
1.326450E-01 |
| Caucasian-vs-Asian |
5.458600E-01 |
| AfricanAmerican-vs-Asian |
9.959600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.338480E-02 |
| Normal-vs-Female |
3.017200E-01 |
| Male-vs-Female |
4.430100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.743800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.616200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.648270E-02 |
| Normal-vs-Age(81-100Yrs) |
2.271800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.130160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.860000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.598200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.435900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.049980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.559200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.870400E-02 |
| Normal-vs-Grade 2 |
4.338000E-01 |
| Normal-vs-Grade 3 |
1.019080E-03 |
| Normal-vs-Grade 4 |
6.376600E-03 |
| Grade 1-vs-Grade 2 |
2.072100E-02 |
| Grade 1-vs-Grade 3 |
9.86979999999527E-05 |
| Grade 1-vs-Grade 4 |
8.839600E-04 |
| Grade 2-vs-Grade 3 |
1.177360E-03 |
| Grade 2-vs-Grade 4 |
1.278340E-02 |
| Grade 3-vs-Grade 4 |
7.257400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.403200E-01 |
| Normal-vs-ccB subtype |
4.056300E-03 |
| ccA subtype-vs-ccB subtype |
3.036000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.110100E-02 |
| Normal-vs-N1 |
7.726800E-01 |
| N0-vs-N1 |
7.320200E-01 |
|
|
